Doxorubicin Resistance in Breast Cancer Cells Is Mediated by Extracellular Matrix Proteins

BMC Cancer - United Kingdom
doi 10.1186/s12885-017-3953-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Extracellular Matrix Induces Doxorubicin-Resistance in Human Osteosarcoma Cells by Suppression of P53 Function

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2007English

Enhancement of Doxorubicin Cytotoxicity by Verapamil in Human Breast Cancer Cells

Journal of Pharmaceutical Research International
2019English

ADAMTS1 Promotes Adhesion to Extracellular Matrix Proteins and Predicts Prognosis in Early Stage Breast Cancer Patients

Cellular Physiology and Biochemistry
Physiology
2019English

Novel Mechanism of Apoptosis Resistance in Cancer Mediated by Extracellular PAR-4

Cancer Research
Cancer ResearchOncology
2012English

Apoptosis Induced by PGC-1β in Breast Cancer Cells Is Mediated by the mTOR Pathway

Oncology Reports
MedicineCancer ResearchOncology
2013English

Quantitative Proteomics Reveals Proteins Associated With Radiotherapy Resistance in Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2008English

Transcription Factor EB Is Involved in Autophagy-Mediated Chemoresistance to Doxorubicin in Human Cancer Cells

Acta Pharmacologica Sinica
MedicinePharmacology
2017English

Integrin-Mediated Interactions With Extracellular Matrix Proteins for Nucleus Pulposus Cells of the Human Intervertebral Disc

Journal of Orthopaedic Research
OrthopedicsSports Medicine
2013English

Extracellular Matrix Derived From High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells Through Αvβ3 Integrin

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy